All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ACURX PHARMACEUTICALS, INC. Last Reported: 4/30/2024 Stock Symbol: ACXP

Business Address

259 LIBERTY AVENUE

STATEN ISLAND , NY US 10305

Mailing Address

259 LIBERTY AVENUE

STATEN ISLAND , NY US 10305
Phone Number: 917-533-1469 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 12/31/2019
Cash and Cash Equivalents -- -- -- -- -- -- -- -- -- $14,459,046.00 $17,095,596.00 $3,175,411.00 $3,406,628.00 $1,974,439.00 $2,483,322.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets -- -- $7,158,051.00 $9,235,777.00 $7,385,421.00 -- $10,945,148.00 $9,209,053.00 -- -- -- -- -- -- --
Property Plant and Equipement -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $9,108,834.00 $7,709,123.00 -- -- -- $9,376,706.00 -- $9,259,300.00 $11,322,300.00 $14,989,628.00 $17,440,145.00 $3,224,020.00 -- -- --
Accounts Payable -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $3,110,242.00 $3,042,438.00 $3,223,378.00 $3,019,408.00 $2,073,982.00 $2,061,685.00 $1,182,080.00 $473,879.00 $633,028.00 $712,437.00 $1,918,639.00 $522,434.00 -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-57,596,742.00 $-53,218,853.00 $-48,104,263.00 $-44,989,282.00 $-41,544,042.00 $-38,641,085.00 $-35,380,574.00 $-31,838,980.00 $-29,218,447.00 $-23,921,223.00 $-19,279,001.00 $-13,800,612.00 -- -- --
Total Stockholders' Equity $5,998,592.00 $4,666,685.00 $3,934,673.00 $6,216,369.00 $5,311,439.00 $7,315,021.00 $9,763,068.00 $8,785,421.00 -- -- -- -- -- -- --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $9,108,834.00 $7,709,123.00 $7,158,051.00 $9,235,777.00 $7,385,421.00 $9,376,706.00 $10,945,148.00 $9,259,300.00 $11,322,300.00 $14,989,628.00 $17,440,145.00 $3,224,020.00 -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $1,555,011.00 $6,043,597.00 $1,348,985.00 $2,751,969.00 $1,015,583.00 $4,754,271.00 $1,591,043.00 $1,730,580.00 $818,888.00 $1,126,972.00 $186,981.00 -- $1,745,446.00 $1,085,469.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- $113,100.00 $208,270.00 -- -- -- -- --
Total Operating Expenses $4,377,889.00 $14,577,768.00 $9,463,178.00 $6,348,197.00 $2,902,957.00 $12,092,776.00 $8,832,265.00 $5,290,670.00 $2,670,138.00 $4,642,222.00 $5,544,892.00 -- $3,507,007.00 $913,360.00 --
Loss from Operations -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.28 $-1.15 $-0.77 $-0.28 $-0.25 $-1.12 $-0.32 $-0.52 $-0.26 $-0.46 -- -- $-0.58 -- --
Weighted Average Shares Basic 15,472,507 12,671,572 12,282,004 11,914,449 11,639,395 10,816,412 11,148,402 10,263,202 10,232,843 10,116,403 -- -- 6,037,254 -- --
Earnings Per Share Diluted $-0.28 $-1.15 $-0.77 $-0.53 $-0.25 $-1.12 $-0.32 $-0.26 $-0.26 $-1.27 -- -- $-0.58 -- --
Weighted Average Shares Diluted 15,472,507 12,671,572 12,282,004 12,186,481 11,639,395 10,816,412 10,551,503 10,263,202 10,232,843 7,988,563 -- -- 6,266,584 -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 -- -- -- --
Common Stock Shares Outstanding 15,757,102 14,468,229 13,005,128 13,005,128 11,671,795 11,627,609 11,592,609 10,263,202 10,263,202 10,126,903 9,916,208 -- -- -- --
Common Stock Value $15,757.00 $14,468.00 $13,005.00 $13,005.00 $11,672.00 $11,628.00 $11,593.00 $10,263.00 $10,263.00 $10,127.00 $9,916.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com